Related Experiment Video

Updated: Aug 6, 2026

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics
08:43

Rat Model of Blood-brain Barrier Disruption to Allow Targeted Neurovascular Therapeutics

Published on: November 30, 2012

[Problems in general management during barbiturate therapy]

S Oda1, M Shimoda, S Yamada

  • 1Department of Neurosurgery, Tokai University School of Medicine.

No Shinkei Geka. Neurological Surgery
|December 1, 1992
PubMed

Insights

Barbiturate therapy for severe head injury and cerebrovascular disease can cause immediate complications like tachycardia and hypotension, and delayed issues such as hypokalemia and liver dysfunction. Careful monitoring is essential to manage these risks in patients undergoing barbiturate treatment.

Area of Science:

  • Neurology
  • Critical Care Medicine
  • Pharmacology

Context:

  • Investigates the safety and efficacy of barbiturate regimens in managing severe neurological conditions.
  • Focuses on patients with severe head injury or cerebrovascular disease requiring intensive treatment.
  • Examines complications associated with intravenous barbiturate administration at 1-4 mg/kg/hr.

Purpose:

  • To analyze immediate and delayed complications arising from barbiturate therapy.
  • To identify the incidence and nature of adverse events associated with barbiturate use.
  • To inform clinical practice regarding the safe administration of barbiturates.

Summary:

  • Barbiturate therapy in 63 patients with severe head injury or cerebrovascular disease revealed immediate complications: tachycardia (25%) and hypotension (22%), more frequent in surgical patients.
  • Delayed complications were common, including hypokalemia (65%), liver dysfunction (38%), infection (33%), cardiac failure (13%), and renal failure (2%).
  • Supportive treatments like dobutamine and dopamine were used to prevent cardiac and renal failure during barbiturate regimens.

Impact:

  • Highlights the significant risk of both immediate and delayed adverse events during barbiturate therapy.
  • Emphasizes the need for vigilant monitoring and proactive management strategies to mitigate barbiturate-induced complications.
  • Provides critical data for clinicians considering barbiturate regimens in neurocritical care settings.

More Related Videos

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury07:07

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury

Published on: February 10, 2020

Related Concept Videos

CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A key...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications